Advances in enteric coating, nanoparticle encapsulation, and peptide stapling are opening pathways to oral bioavailability a potential game-changer for therapeutic applications
The biggest problem B12 deficient patients face once theyve achieved a diagnosis is desperate under treatment
Tesamorelin, a more potent GHRH analog, has Phase 3 human trial data for visceral fat reduction in HIV-associated lipodystrophy, which provides some mechanistic validation for the class
Follow proper administration protocols for IM or IV use
Every patient receives individualized medical assessment, customized treatment protocols, integration with your overall healthcare, safety monitoring by a licensed physician, access to diagnostic testing when appropriate, and the ability to address complications or concerns immediately